ATE516019T1 - Quellbare dosierform mit gellan-gummit - Google Patents
Quellbare dosierform mit gellan-gummitInfo
- Publication number
- ATE516019T1 ATE516019T1 AT05739537T AT05739537T ATE516019T1 AT E516019 T1 ATE516019 T1 AT E516019T1 AT 05739537 T AT05739537 T AT 05739537T AT 05739537 T AT05739537 T AT 05739537T AT E516019 T1 ATE516019 T1 AT E516019T1
- Authority
- AT
- Austria
- Prior art keywords
- dosage form
- spindle
- glucose
- viscosity
- oral administration
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title abstract 4
- 229920002148 Gellan gum Polymers 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 239000012736 aqueous medium Substances 0.000 abstract 2
- 235000010492 gellan gum Nutrition 0.000 abstract 2
- 239000000216 gellan gum Substances 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003792 electrolyte Substances 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- 239000002357 osmotic agent Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 230000008961 swelling Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/0015—Devices specially adapted for taking medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/0015—Devices specially adapted for taking medicines
- A61J7/0023—Spoons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J7/00—Devices for administering medicines orally, e.g. spoons; Pill counting devices; Arrangements for time indication or reminder for taking medicine
- A61J7/0015—Devices specially adapted for taking medicines
- A61J7/0046—Cups, bottles or bags
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Jellies, Jams, And Syrups (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200400755 | 2004-05-11 | ||
| PCT/DK2005/000317 WO2005107713A2 (en) | 2004-05-11 | 2005-05-11 | Swellable dosage form comprising gellan gum |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE516019T1 true ATE516019T1 (de) | 2011-07-15 |
Family
ID=34967246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05739537T ATE516019T1 (de) | 2004-05-11 | 2005-05-11 | Quellbare dosierform mit gellan-gummit |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US8383154B2 (de) |
| EP (2) | EP1758557B1 (de) |
| JP (1) | JP5154924B2 (de) |
| AT (1) | ATE516019T1 (de) |
| CA (1) | CA2566793C (de) |
| DK (2) | DK1758557T3 (de) |
| ES (2) | ES2517244T3 (de) |
| WO (1) | WO2005107713A2 (de) |
Families Citing this family (72)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6733780B1 (en) | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
| US20040234602A1 (en) | 2001-09-21 | 2004-11-25 | Gina Fischer | Polymer release system |
| WO2003024430A1 (en) | 2001-09-21 | 2003-03-27 | Egalet A/S | Morphine polymer release system |
| EP1610767B1 (de) | 2003-03-26 | 2011-01-19 | Egalet A/S | Morphin-system mit kontrollierter freisetzung |
| US7985418B2 (en) | 2004-11-01 | 2011-07-26 | Genzyme Corporation | Aliphatic amine polymer salts for tableting |
| US20060275366A1 (en) * | 2005-06-02 | 2006-12-07 | Schering Corporation | Controlled-release formulation |
| WO2007035313A2 (en) * | 2005-09-15 | 2007-03-29 | Genzyme Corporation | Sachet formulation for amine polymers |
| EP1937414A4 (de) * | 2005-09-19 | 2013-01-02 | Univ Witwatersrand Jhb | Oromucosale arzneimittelverabreichungsform |
| NZ577560A (en) * | 2007-01-16 | 2012-01-12 | Egalet Ltd | Use of i) a polyglycol and ii) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse |
| US11241420B2 (en) | 2007-04-11 | 2022-02-08 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| US20160331729A9 (en) | 2007-04-11 | 2016-11-17 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| US8821928B2 (en) | 2007-06-04 | 2014-09-02 | Egalet Ltd. | Controlled release pharmaceutical compositions for prolonged effect |
| US8563066B2 (en) | 2007-12-17 | 2013-10-22 | New World Pharmaceuticals, Llc | Sustained release of nutrients in vivo |
| CA2716872C (en) | 2008-02-29 | 2015-02-10 | Ferrosan Medical Devices A/S | Device for promotion of hemostasis and/or wound healing |
| US9237972B2 (en) * | 2008-12-16 | 2016-01-19 | Kimberly-Clark Worldwide, Inc. | Liquid surfactant compositions that adhere to surfaces and solidify and swell in the presence of water and articles using the same |
| EP2208493A1 (de) * | 2009-01-15 | 2010-07-21 | Sandoz AG | Verfahren und Vorrichtung zur oralen Anwendung einer Zusammensetzung |
| CA2750400A1 (en) * | 2009-01-26 | 2010-07-29 | Egalet A/S | Controlled release formulations with continuous efficacy |
| AU2010211376B2 (en) * | 2009-02-06 | 2013-08-22 | Egalet Ltd. | Pharmaceutical compositions resistant to abuse |
| EP2393484A1 (de) | 2009-02-06 | 2011-12-14 | Egalet Ltd. | Gegen missbrauch durch alkoholeinnahme widerstandsfähige zusammensetzung mit unmittelbarer freisetzung |
| WO2010105103A1 (en) | 2009-03-11 | 2010-09-16 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| CA2766179A1 (en) | 2009-06-24 | 2010-12-29 | Egalet Ltd. | Controlled release formulations |
| FR2955252B1 (fr) * | 2010-01-21 | 2012-03-23 | Patrick Lesage | Materiau d'insertion destine a elargir le sillon gingival |
| RU2012143739A (ru) | 2010-03-15 | 2014-04-20 | Ферросан Медикал Дивайсиз А/С | Способ ускорения остановки кровотечения и/или заживления ран |
| WO2012037117A1 (en) | 2010-09-13 | 2012-03-22 | Bev-Rx, Inc. | Aqueous drug delivery system comprising off - flavor masking agent |
| US9132291B2 (en) | 2010-10-05 | 2015-09-15 | Dfb Technology, Ltd. | Water-in-oil emulsion compositions containing gellan gum for topical delivery of active ingredients to the skin or mucosa |
| US8691275B2 (en) | 2011-01-28 | 2014-04-08 | Zx Pharma, Llc | Controlled-release melatonin compositions and related methods |
| US9532952B2 (en) | 2011-01-28 | 2017-01-03 | Physician's Seal, LLC | Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients |
| US8808736B2 (en) | 2011-02-11 | 2014-08-19 | Zx Pharma, Llc | Enteric coated multiparticulate controlled release peppermint oil composition and related methods |
| US8911780B2 (en) | 2011-02-11 | 2014-12-16 | Zx Pharma, Llc | Multiparticulate L-menthol formulations and related methods |
| BR112013020404B1 (pt) | 2011-02-11 | 2022-04-05 | Société Des Produits Nestlé S.A | Formulação de multiparticulado de lmentol, seu método de produção, ecomposição de multiparticulado |
| JP5226097B2 (ja) * | 2011-03-30 | 2013-07-03 | 株式会社ファンケル | サプリメントを内包する蓋体とサプリメント分散媒を充填したボトルからなるボトル入り飲料 |
| US9119793B1 (en) | 2011-06-28 | 2015-09-01 | Medicis Pharmaceutical Corporation | Gastroretentive dosage forms for doxycycline |
| US8898912B2 (en) * | 2011-08-29 | 2014-12-02 | Adam Leffler | Spoon delivery device |
| CA2852447A1 (en) * | 2011-10-19 | 2013-04-25 | R.P. Scherer Technologies, Llc | Two phase pharmaceutical delivery system |
| WO2013095215A1 (en) * | 2011-12-19 | 2013-06-27 | Dilaforette Ab | Low anticoagulant heparins |
| EP2822474B1 (de) | 2012-03-06 | 2018-05-02 | Ferrosan Medical Devices A/S | Druckbehälter mit einer blutstillenden paste |
| US9452135B2 (en) | 2012-03-20 | 2016-09-27 | Particle Dynamics International, Llc | Gelling agent-based dosage form |
| CN104394854A (zh) * | 2012-05-08 | 2015-03-04 | 美全诺药业 | 具有增强活性和降低毒性的包括硝呋替莫的硝基呋喃的新型制剂 |
| EP2825216B1 (de) | 2012-06-12 | 2015-08-19 | Ferrosan Medical Devices A/S | Trockene blutstillende zusammensetzung |
| KR20150059167A (ko) | 2012-07-06 | 2015-05-29 | 에갈렛 리미티드 | 제어된 방출을 위한 남용 제지 약학적 조성물 |
| EP2934422A4 (de) * | 2012-12-23 | 2016-07-20 | Vadim Zelikman | Gellangummiträger für ein medikament, mittel und verfahren |
| US10842802B2 (en) | 2013-03-15 | 2020-11-24 | Medicis Pharmaceutical Corporation | Controlled release pharmaceutical dosage forms |
| KR101787225B1 (ko) | 2013-04-23 | 2017-10-18 | 제트엑스 파마 엘엘씨 | 단백질성 서브코트를 갖는 장용 코팅된 다중 미립자 조성물 |
| WO2014202760A2 (en) | 2013-06-21 | 2014-12-24 | Ferrosan Medical Devices A/S | Vacuum expanded dry composition and syringe for retaining same |
| KR20160023695A (ko) * | 2013-06-26 | 2016-03-03 | 유니버시티 오브 아이오와 리써치 파운데이션 | 구강 약물 전달 디바이스 및 그 사용 방법 |
| JP6489485B2 (ja) | 2013-12-11 | 2019-03-27 | フェロサン メディカル デバイシーズ エイ／エス | 押し出し増強因子を含んでいる乾燥組成物 |
| TWI720451B (zh) | 2014-02-13 | 2021-03-01 | 美商英塞特控股公司 | 作為lsd1抑制劑之環丙胺 |
| KR102421235B1 (ko) | 2014-02-13 | 2022-07-15 | 인사이트 코포레이션 | Lsd1 저해제로서 사이클로프로필아민 |
| CA2943422C (en) * | 2014-04-29 | 2020-03-10 | The Procter & Gamble Company | Bismuth-containing liquid pharmaceutical suspensions |
| US9695167B2 (en) | 2014-07-10 | 2017-07-04 | Incyte Corporation | Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors |
| CN105560281A (zh) * | 2014-10-08 | 2016-05-11 | 华仁药业股份有限公司 | 一种混合糖电解质注射液及其制备方法 |
| CN106999621B (zh) | 2014-10-13 | 2020-07-03 | 弗罗桑医疗设备公司 | 用于止血和伤口愈合的干组合物 |
| EP3237041B1 (de) | 2014-12-24 | 2020-01-29 | Ferrosan Medical Devices A/S | Spritze für die enthaltung und die mischung erster und zweiter substanzen |
| US10792301B2 (en) * | 2015-02-13 | 2020-10-06 | The University Of Toledo | Therapeutic polysaccharide midi-GAGR and related materials and methods |
| KR102659373B1 (ko) | 2015-04-03 | 2024-04-23 | 인사이트 홀딩스 코포레이션 | Lsd1 저해제로서 헤테로사이클릭 화합물 |
| US20170042806A1 (en) | 2015-04-29 | 2017-02-16 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
| JO3456B1 (ar) | 2015-05-13 | 2020-07-05 | H Lundbeck As | فيروتيوكسيتين بيروجلوتامات |
| GR1008819B (el) | 2015-05-22 | 2016-08-01 | Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων | Φαρμακευτικο σκευασμα που περιλαμβανει ατομοξετινη και μεθοδος παρασκευης αυτου |
| WO2017005590A1 (en) | 2015-07-03 | 2017-01-12 | Ferrosan Medical Devices A/S | Syringe for mixing two components and for retaining a vacuum in a storage condition |
| EP3334709A1 (de) | 2015-08-12 | 2018-06-20 | Incyte Corporation | Salze eines lsd1-hemmers |
| CA3023305A1 (en) | 2016-05-06 | 2017-11-09 | Physician's Seal, LLC | Valerian composition and related methods |
| US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
| US10806789B2 (en) | 2017-05-12 | 2020-10-20 | The LIV Group Inc. | Composition for enhanced absorption of supplements |
| AU2019266529B2 (en) | 2018-05-09 | 2024-05-23 | Ethicon Inc. | Method for preparing a haemostatic composition |
| US10968200B2 (en) | 2018-08-31 | 2021-04-06 | Incyte Corporation | Salts of an LSD1 inhibitor and processes for preparing the same |
| EP3699223A1 (de) * | 2019-02-19 | 2020-08-26 | LANXESS Deutschland GmbH | Inline ultraschallkontrolle zur detektion des anvernetzens einer kautschukmischung bei der in situ silanisierung von hellen füllstoffen |
| US20220400724A1 (en) * | 2019-10-28 | 2022-12-22 | R.P. Scherer Technologies, Llc | Delayed release softgel capsules in higher ph environment |
| WO2022011341A1 (en) | 2020-07-10 | 2022-01-13 | Adare Pharmaceuticals, Inc. | Swellable oral pharmaceutical compositions |
| US20240197635A1 (en) * | 2021-03-03 | 2024-06-20 | Veramorph Llc | Dissociating polymer matrix compositions of fulvestrant and methods of their making and use |
| CN116509842B (zh) * | 2021-09-09 | 2024-09-20 | 厦门君德医药科技有限公司 | 药物组合物及其制备方法和应用 |
| WO2024064359A2 (en) * | 2022-09-25 | 2024-03-28 | Albert Ludwig University Of Freiburg | Marine polysaccharide networks |
| CN116449023B (zh) * | 2023-04-10 | 2024-07-12 | 浙江伊利康生物技术有限公司 | 一种血清淀粉样蛋白a检测试剂盒及其制备方法 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4994260A (en) * | 1982-05-28 | 1991-02-19 | Astra Lakemedel Aktiebolag | Pharmaceutical mixture |
| US4590075A (en) * | 1984-08-27 | 1986-05-20 | Warner-Lambert Company | Elastomer encapsulation of flavors and sweeteners, long lasting flavored chewing gum compositions based thereon and process of preparation |
| US4824681A (en) | 1986-12-19 | 1989-04-25 | Warner-Lambert Company | Encapsulated sweetener composition for use with chewing gum and edible products |
| GB8702411D0 (en) * | 1987-02-03 | 1987-03-11 | Zyma Sa | Swellable pellets |
| US5234957A (en) | 1991-02-27 | 1993-08-10 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
| US5178878A (en) | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
| IL100398A0 (en) | 1990-12-17 | 1992-09-06 | Redding Bruce K | Microencapsulated sweeteners for use in baked goods |
| US5126151A (en) | 1991-01-24 | 1992-06-30 | Warner-Lambert Company | Encapsulation matrix |
| IL108366A (en) * | 1993-03-11 | 1999-11-30 | Taro Vit Ind Ltd | Semi-solid pharmaceutical compounds and a device for their use |
| US5881926A (en) * | 1993-03-11 | 1999-03-16 | Taro Pharmaceutical Industries, Ltd. | Pharmaceutical compositions in semisolid form and a device for administration thereof |
| ATE260646T1 (de) | 1996-04-16 | 2004-03-15 | Novartis Consumer Health Sa | Schnell zerfallende orale dosierungsform |
| EP0918513B1 (de) * | 1996-08-15 | 2000-12-06 | Losan Pharma GmbH | Gut schluckbare orale arzneiform |
| JP2001508411A (ja) * | 1996-11-29 | 2001-06-26 | モンサント・カンパニー | 生物学的活性成分の経口投与のための潤滑性自立型（インタクト）ゲル |
| WO1999022769A1 (en) * | 1997-10-31 | 1999-05-14 | Monsanto Company | Gellan gum tablet coating |
| JP3524359B2 (ja) * | 1997-12-26 | 2004-05-10 | 伊那食品工業株式会社 | 咀嚼・嚥下困難者用の摂食補助用糊料 |
| US6071523A (en) * | 1998-06-03 | 2000-06-06 | Taro Pharmaceuticals Industries, Ltd. | Spill resistant pharmaceutical compositions in semi-solid form |
| SK284948B6 (sk) | 2000-04-06 | 2006-03-02 | Zentiva, A. S. | Liečivý prípravok s obsahom vápnika alebo zmesi vápnika a vitamínu D, alebo zmesi vápnika a horčíka v novej liekovej forme |
| US6488962B1 (en) * | 2000-06-20 | 2002-12-03 | Depomed, Inc. | Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms |
| US6474418B2 (en) | 2000-12-07 | 2002-11-05 | Frank's International, Inc. | Wellbore fluid recovery system and method |
| AU2002237736A1 (en) | 2000-12-21 | 2002-07-01 | Oscar M. Bassinson | Personal medication dispensing card |
| US6589955B2 (en) | 2001-06-20 | 2003-07-08 | Bristol-Myers Squibb Company | Pediatric formulation of gatifloxacin |
| EP1463489A1 (de) * | 2001-09-28 | 2004-10-06 | McNEIL-PPC, INC. | Zusammengesetzte dosierformen |
| HRP20020923A2 (en) | 2001-11-23 | 2003-10-31 | Glaxo Group Ltd | Pharmaceutical composition |
| JP3835544B2 (ja) | 2002-09-10 | 2006-10-18 | 明治乳業株式会社 | ゼリー乾燥物 |
| KR101179541B1 (ko) | 2003-04-25 | 2012-09-05 | 레킷트 벵키저 헬스케어(유케이)리미티드 | 증점성 조성물 |
| CA2533165A1 (en) * | 2003-07-21 | 2005-01-27 | Bio-Dar Ltd. | Gellan gum based oral controlled release dosage forms- a novel platform technology for gastric retention |
| US9109434B2 (en) | 2013-06-09 | 2015-08-18 | Schlumberger Technology Corporation | System and method for estimating oil formation volume factor downhole |
-
2005
- 2005-05-11 DK DK05739537.8T patent/DK1758557T3/da active
- 2005-05-11 EP EP05739537A patent/EP1758557B1/de active Active
- 2005-05-11 WO PCT/DK2005/000317 patent/WO2005107713A2/en active Application Filing
- 2005-05-11 ES ES10175613.8T patent/ES2517244T3/es active Active
- 2005-05-11 ES ES05739537T patent/ES2370729T3/es active Active
- 2005-05-11 AT AT05739537T patent/ATE516019T1/de active
- 2005-05-11 US US11/596,123 patent/US8383154B2/en active Active
- 2005-05-11 DK DK10175613.8T patent/DK2258349T3/da active
- 2005-05-11 JP JP2007511867A patent/JP5154924B2/ja not_active Expired - Fee Related
- 2005-05-11 EP EP10175613.8A patent/EP2258349B1/de active Active
- 2005-05-11 CA CA2566793A patent/CA2566793C/en active Active
-
2011
- 2011-08-18 US US13/212,679 patent/US8383155B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP5154924B2 (ja) | 2013-02-27 |
| CA2566793C (en) | 2013-07-16 |
| DK1758557T3 (da) | 2011-10-24 |
| WO2005107713A3 (en) | 2006-05-18 |
| EP1758557A2 (de) | 2007-03-07 |
| ES2370729T3 (es) | 2011-12-22 |
| US20080299199A1 (en) | 2008-12-04 |
| WO2005107713A2 (en) | 2005-11-17 |
| US8383154B2 (en) | 2013-02-26 |
| EP2258349A3 (de) | 2012-04-04 |
| JP2007537169A (ja) | 2007-12-20 |
| DK2258349T3 (da) | 2014-10-13 |
| EP1758557B1 (de) | 2011-07-13 |
| EP2258349B1 (de) | 2014-07-16 |
| US20120039969A1 (en) | 2012-02-16 |
| CA2566793A1 (en) | 2005-11-17 |
| EP2258349A2 (de) | 2010-12-08 |
| ES2517244T3 (es) | 2014-11-03 |
| US8383155B2 (en) | 2013-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE516019T1 (de) | Quellbare dosierform mit gellan-gummit | |
| US12053552B2 (en) | Functional wound dressing | |
| Teng et al. | Recent development of alginate-based materials and their versatile functions in biomedicine, flexible electronics, and environmental uses | |
| JP4959328B2 (ja) | 温度感応性状態変化ハイドロゲル組成物及びその製造方法 | |
| US11937922B2 (en) | pH-triggered diagnostic wound dressing | |
| TW460288B (en) | Thermally-gelling ophthalmic drug delivery vehicles containing cellulose ethers | |
| US8709480B2 (en) | Adhering composition and method of applying the same | |
| EP3643331A1 (de) | Ph-ausgelöster therapeutischer wundverband | |
| ES2355613T3 (es) | Composiciones en dos fases de polímero hidrofóbico superabsorbente. | |
| Gomaa et al. | Laser-engineered dissolving microneedles for active transdermal delivery of nadroparin calcium | |
| EP3643330A1 (de) | Ph-ausgelöste gepufferte wundauflage | |
| BRPI0907965B1 (pt) | produto para instalações sanitárias, seus usos e conjunto de limpeza para vaso sanitário compreendendo o mesmo | |
| CA2993415A1 (en) | Composite bioadhesive sealant | |
| BRPI0113539B1 (pt) | processo para a preparação de composições farmacêuticas para uso com formulações de gelatina macia | |
| SE0502900L (sv) | Komposition och metod | |
| Naharros‐Molinero et al. | Shell formulation in soft gelatin capsules: Design and characterization | |
| Cholewinski et al. | Glycerol-stabilized algae–mussel-inspired adhesives for underwater bonding | |
| AU2004212746B2 (en) | Bioadhesive liquid composition which is substantially free of water | |
| Huang et al. | Biodegradable underwater tissue adhesive enabled by dynamic poly (thioctic acid) network | |
| ES2862403T3 (es) | Una composición de múltiples componentes para producir un hidrogel inhibidor de la corrosión | |
| WO2021165558A1 (es) | Capsula galénica rompible | |
| KR20160101957A (ko) | 제어가능하게 분해가능한 조성물 및 방법 | |
| CN219456122U (zh) | 一种用于体外释放试验的偏差控制装置 | |
| Javed et al. | FORMULATION AND EVALUATION OF GASTRORETENTIVE IN SITU GELLING SYSTEM OF MITIGLINIDE | |
| Kanehira et al. | Rationale behind the design and comparative evaluation of an all-in-one self-etch model adhesive |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1758557 Country of ref document: EP |